1887

Abstract

Infection with has been implicated as a potential risk factor for atherosclerosis. This study was designed to investigate the mechanisms of the anti-chlamydial activity of aspirin. A reporter gene assay for NF-κB activity, immunoblot analysis for cyclo-oxygenase (COX)-2 and radioimmunoassay for prostaglandin E (PGE) were performed. Following infection of HEp-2 cells with , NF-κB was activated, COX-2 was induced and PGE was elevated. Aspirin inhibited NF-κB activation at a concentration of 0.1 mM, partially inhibited COX-2 induction and blocked PGE synthesis completely. In addition, high doses of aspirin (1 and 2 mM) inhibited chlamydial growth in HEp-2 cells, decreasing the number and size of inclusion bodies; this effect could be overcome by adding tryptophan to the culture. Indomethacin also blocked the synthesis of PGE, but had no effect on COX-2 expression or chlamydial growth. These results indicate that aspirin not only has an anti-inflammatory activity through prevention of NF-κB activation but also has anti-chlamydial activity at high doses, possibly through depletion of tryptophan in HEp-2 cells.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.04992-0
2003-05-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/5/JM520508.html?itemId=/content/journal/jmm/10.1099/jmm.0.04992-0&mimeType=html&fmt=ahah

References

  1. Appleby, S. B., Ristimaki, A., Neilson, K., Narko, K. & Hla, T. ( 1994;). Structure of the human cyclo-oxygenase-2 gene. Biochem J 302, 723–727.
    [Google Scholar]
  2. Baeuerle, P. A. & Baltimore, D. ( 1988;). IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540–546.[CrossRef]
    [Google Scholar]
  3. Baeuerle, P. A. & Henkel, T. ( 1994;). Function and activation of NF-κB in the immune system. Annu Rev Immunol 12, 141–179.[CrossRef]
    [Google Scholar]
  4. Brand, K., Page, S., Rogler, G. & 7 other authors ( 1996;). Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion. J Clin Invest 97, 1715–1722.[CrossRef]
    [Google Scholar]
  5. Budker, V., Gurevich, V., Hagstrom, J. E., Bortzov, F. & Wolff, J. A. ( 1996;). pH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nat Biotechnol 14, 760–764.[CrossRef]
    [Google Scholar]
  6. Caldwell, H. D., Kromhout, J. & Schachter, J. ( 1981;). Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31, 1161–1176.
    [Google Scholar]
  7. Chu, S. C., Marks-Konczalik, J., Wu, H. P., Banks, T. C. & Moss, J. ( 1998;). Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248, 871–878.[CrossRef]
    [Google Scholar]
  8. Collins, T. ( 1993;). Endothelial nuclear factor-κB and initiation of the atherosclerotic lesion. Lab Invest 68, 499–508.
    [Google Scholar]
  9. Cook, P. J., Honeybourne, D., Lip, G. Y., Beevers, D. G., Wise, R. & Davies, P. ( 1998;). Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. Stroke 29, 404–410.[CrossRef]
    [Google Scholar]
  10. Cybulsky, M. I. & Gimbrone, M. A., Jr ( 1991;). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791.[CrossRef]
    [Google Scholar]
  11. D'Acquisto, F., Iuvone, T., Rombola, L., Sautebin, L., Di Rosa, M. & Carnuccio, R. ( 1997;). Involvement of NF-κB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 418, 175–178.[CrossRef]
    [Google Scholar]
  12. Dechend, R., Maass, M., Gieffers, J., Dietz, R., Scheidereit, C., Leutz, A. & Gulba, D. C. ( 1999;). Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100, 1369–1373.[CrossRef]
    [Google Scholar]
  13. Dichtl, W., Nilsson, L., Goncalves, I., Ares, M. P., Banfi, C., Calara, F., Hamsten, A., Eriksson, P. & Nilsson, J. ( 1999;). Very low-density lipoprotein activates nuclear factor-κB in endothelial cells. Circ Res 84, 1085–1094.[CrossRef]
    [Google Scholar]
  14. Gawaz, M., Neumann, F. J., Dickfeld, T. & 8 other authors ( 1998;). Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98, 1164–1171.[CrossRef]
    [Google Scholar]
  15. Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K. & Isakson, P. C. ( 1999;). Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339, 607–614.[CrossRef]
    [Google Scholar]
  16. Goodwin, J. S., Bankhurst, A. D. & Messner, R. P. ( 1977;). Suppression of human T-cell mitogenesis by prostaglandin.Existence of a prostaglandin-producing suppressor cell. J Exp Med 146, 1719–1734.[CrossRef]
    [Google Scholar]
  17. Grayston, J. T. ( 1992;). Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 15, 757–761.[CrossRef]
    [Google Scholar]
  18. Grayston, J. T., Kuo, C. C., Wang, S. P. & Altman, J. ( 1986;). A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 315, 161–168.[CrossRef]
    [Google Scholar]
  19. Grayston, J. T., Campbell, L. A., Kuo, C. C., Mordhorst, C. H., Saikku, P., Thom, D. H. & Wang, S. P. ( 1990;). A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161, 618–625.[CrossRef]
    [Google Scholar]
  20. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B. & Davis, R. J. ( 1996;). Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15, 2760–2770.
    [Google Scholar]
  21. He, X. & Stuart, J. M. ( 1999;). Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL-2 and IL-4. J Immunol 163, 6173–6179.
    [Google Scholar]
  22. Jackson, L. A., Campbell, L. A., Kuo, C. C., Rodriguez, D. I., Lee, A. & Grayston, J. T. ( 1997;). Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176, 292–295.[CrossRef]
    [Google Scholar]
  23. Kol, A., Bourcier, T., Lichtman, A. H. & Libby, P. ( 1999;). Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103, 571–577.[CrossRef]
    [Google Scholar]
  24. Kopp, E. & Ghosh, S. ( 1994;). Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956–959.[CrossRef]
    [Google Scholar]
  25. Krull, M., Klucken, A. C., Wuppermann, F. N. & 7 other authors ( 1999;). Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 162, 4834–4841.
    [Google Scholar]
  26. Kuo, C. C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L. & Grayston, J. T. ( 1993;). Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167, 841–849.[CrossRef]
    [Google Scholar]
  27. Marks-Konczalik, J., Chu, S. C. & Moss, J. ( 1998;). Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J Biol Chem 273, 22201–22208.[CrossRef]
    [Google Scholar]
  28. Matsushima, H., Shirai, M., Ouchi, K., Yamashita, K., Kakutani, T., Furukawa, S. & Nakazawa, T. ( 1999;). Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells. Infect Immun 67, 3175–3179.
    [Google Scholar]
  29. Melnick, S. L., Shahar, E., Folsom, A. R., Grayston, J. T., Sorlie, P. D., Wang, S. P. & Szklo, M. ( 1993;). Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 95, 499–504.[CrossRef]
    [Google Scholar]
  30. Miyashita, N., Toyota, E., Sawayama, T. & Matsushima, T. ( 1998;). An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan. Eur Heart J 19, 971. 971.[CrossRef]
    [Google Scholar]
  31. Molestina, R. E., Miller, R. D., Lentsch, A. B., Ramirez, J. A. & Summersgill, J. T. ( 2000;). Requirement for NF-κB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells. Infect Immun 68, 4282–4288.[CrossRef]
    [Google Scholar]
  32. Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z. & Collins, T. ( 1992;). Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176, 1583–1593.[CrossRef]
    [Google Scholar]
  33. Ouchi, K., Fujii, B., Kanamoto, Y., Karita, M., Shirai, M. & Nakazawa, T. ( 1998;). Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases. J Med Microbiol 47, 907–913.[CrossRef]
    [Google Scholar]
  34. Pantoja, L. G., Miller, R. D., Ramirez, J. A., Molestina, R. E. & Summersgill, J. T. ( 2000;). Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity. Infect Immun 68, 6478–6481.[CrossRef]
    [Google Scholar]
  35. Pantoja, L. G., Miller, R. D., Ramirez, J. A., Molestina, R. E. & Summersgill, J. T. ( 2001;). Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun 69, 7927–7932.[CrossRef]
    [Google Scholar]
  36. Pistritto, G., Franzese, O., Pozzoli, G., Mancuso, C., Tringali, G., Preziosi, P. & Navarra, P. ( 1999;). Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor κB. Biochem Biophys Res Commun 263, 570–574.[CrossRef]
    [Google Scholar]
  37. Poston, R. N., Haskard, D. O., Coucher, J. R., Gall, N. P. & Johnson-Tidey, R. R. ( 1992;). Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140, 665–673.
    [Google Scholar]
  38. Ramirez, J. A. ( 1996;). Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125, 979–982.[CrossRef]
    [Google Scholar]
  39. Ross, R. ( 1993;). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809.[CrossRef]
    [Google Scholar]
  40. Saikku, P., Leinonen, M., Mattila, K., Ekman, M. R., Nieminen, M. S., Makela, P. H., Huttunen, J. K. & Valtonen, V. ( 1988;). Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii , 983–986.
    [Google Scholar]
  41. Shaper, N. L., Hardiun-Lepers, A. & Shaper, J. H. ( 1994;). Male germ cell expression of murine β4-galactosyltransferase.A 796-base pair genomic region, containing two cAMP-responsive element (CRE)-like elements, mediates male germ cell-specific expression in transgenic mice. J Biol Chem 269, 25165–25171.
    [Google Scholar]
  42. Sharma, S. A., Tummuru, M. K. R., Blaser, M. J. & Kerr, L. D. ( 1998;). Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells. J Immunol 160, 2401–2407.
    [Google Scholar]
  43. Shirai, M., Hirakawa, H., Kimoto, M. & 8 other authors ( 2000;). Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res 28, 2311–2314.[CrossRef]
    [Google Scholar]
  44. Shor, A., Kuo, C. C. & Patton, D. L. ( 1992;). Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82, 158–161.
    [Google Scholar]
  45. Siebenlist, U., Franzoso, G. & Brown, K. ( 1994;). Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10, 405–455.[CrossRef]
    [Google Scholar]
  46. Song, Y. G., Kwon, H. M., Kim, J. M. & 10 other authors ( 2000;). Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J 41, 319–327.[CrossRef]
    [Google Scholar]
  47. Speir, E., Yu, Z. X., Ferrans, V. J., Huang, E. S. & Epstein, S. E. ( 1998;). Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 83, 210–216.[CrossRef]
    [Google Scholar]
  48. Tiran, A., Gruber, H. J., Graier, W. F., Wagner, A. H., van Leeuwen, E. B. M. & Tiran, B. ( 2002;). Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-κB activation, cytokine expression, and bacterial development in human endothelial cells. Arterioscler Thromb Vasc Biol 22, 1075–1080.[CrossRef]
    [Google Scholar]
  49. Traenckner, E. B., Wilk, S. & Baeuerle, P. A. ( 1994;). A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13, 5433–5441.
    [Google Scholar]
  50. Wimmer, M. L. J., Sandmann-Strupp, R., Saikku, P. & Haberl, R. L. ( 1996;). Association of chlamydial infection with cerebrovascular disease. Stroke 27, 2207–2210.[CrossRef]
    [Google Scholar]
  51. Yamashita, K., Ouchi, K., Shirai, M., Gondo, T., Nakazawa, T. & Ito, H. ( 1998;). Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29, 773–778.[CrossRef]
    [Google Scholar]
  52. Yin, M. J., Yamamoto, Y. & Gaynor, R. B. ( 1998;). The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396, 77–80.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.04992-0
Loading
/content/journal/jmm/10.1099/jmm.0.04992-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error